JP2007277223A - Ｈｔｌｖ−ｉ関連脊髄症の予防・治療剤およびアポトーシス促進剤 - Google Patents

Ｈｔｌｖ−ｉ関連脊髄症の予防・治療剤およびアポトーシス促進剤 Download PDF

Info

Publication number
JP2007277223A
JP2007277223A JP2007062511A JP2007062511A JP2007277223A JP 2007277223 A JP2007277223 A JP 2007277223A JP 2007062511 A JP2007062511 A JP 2007062511A JP 2007062511 A JP2007062511 A JP 2007062511A JP 2007277223 A JP2007277223 A JP 2007277223A
Authority
JP
Japan
Prior art keywords
htlv
allicin
analog
therapeutic agent
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007062511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007277223A5 (enExample
Inventor
Tatsufumi Nakamura
龍文 中村
Yoshihiro Nishiura
義博 西浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagasaki University NUC
Original Assignee
Nagasaki University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagasaki University NUC filed Critical Nagasaki University NUC
Priority to JP2007062511A priority Critical patent/JP2007277223A/ja
Publication of JP2007277223A publication Critical patent/JP2007277223A/ja
Publication of JP2007277223A5 publication Critical patent/JP2007277223A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007062511A 2006-03-13 2007-03-12 Ｈｔｌｖ−ｉ関連脊髄症の予防・治療剤およびアポトーシス促進剤 Pending JP2007277223A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007062511A JP2007277223A (ja) 2006-03-13 2007-03-12 Ｈｔｌｖ−ｉ関連脊髄症の予防・治療剤およびアポトーシス促進剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006067576 2006-03-13
JP2007062511A JP2007277223A (ja) 2006-03-13 2007-03-12 Ｈｔｌｖ−ｉ関連脊髄症の予防・治療剤およびアポトーシス促進剤

Publications (2)

Publication Number Publication Date
JP2007277223A true JP2007277223A (ja) 2007-10-25
JP2007277223A5 JP2007277223A5 (enExample) 2010-04-22

Family

ID=38679048

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007062511A Pending JP2007277223A (ja) 2006-03-13 2007-03-12 Ｈｔｌｖ−ｉ関連脊髄症の予防・治療剤およびアポトーシス促進剤

Country Status (1)

Country Link
JP (1) JP2007277223A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013084532A1 (ja) * 2011-12-08 2013-06-13 国立大学法人 長崎大学 排尿障害の予防・治療剤
WO2023080157A1 (ja) * 2021-11-02 2023-05-11 国立大学法人東京大学 Ｈｔｌｖ－１関連脊髄症（ｈａｍ）の治療又は予防剤、並びに、ｈａｍの治療有効性判定方法、活動性評価方法又は診断方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04108728A (ja) * 1990-08-27 1992-04-09 Kanebo Ltd マイクロカプセル及び繊維構造物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04108728A (ja) * 1990-08-27 1992-04-09 Kanebo Ltd マイクロカプセル及び繊維構造物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012045675; 中村龍文ら: ＨＴＬＶ-Ｉプロテアーゼ阻害剤によるＨＡＭ治療法の開発ならびにＨＡＭ発症予防に関する研究　平成１６年 , 200503, ｐ．４-５，２７-２９ *
JPN6012045677; 西浦義博ら: 'アリシンによるＨＴＬＶ-Ｉ感染Ｔ細胞に対する障害性の検討' 日本神経学会総会プログラム・抄録集 ４６, 2005, ｐ．１３２ *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013084532A1 (ja) * 2011-12-08 2013-06-13 国立大学法人 長崎大学 排尿障害の予防・治療剤
JPWO2013084532A1 (ja) * 2011-12-08 2015-04-27 国立大学法人 長崎大学 排尿障害の予防・治療剤
WO2023080157A1 (ja) * 2021-11-02 2023-05-11 国立大学法人東京大学 Ｈｔｌｖ－１関連脊髄症（ｈａｍ）の治療又は予防剤、並びに、ｈａｍの治療有効性判定方法、活動性評価方法又は診断方法

Similar Documents

Publication Publication Date Title
Sardana et al. Hydroxychloroquine in dermatology and beyond: recent update
Perrot et al. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient
JP2022058443A (ja) 全身性エリテマトーデスの治療のための３－（４－（（４－（モルホリノメチル－ベンジル）オキシ）－１－オキソイソインドリン－２－イル）ピペリジン－２，６－ジオン
JP7617652B2 (ja) 筋萎縮性側索硬化症（ａｌｓ）および他の神経変性疾患の処置のための組成物および方法
JP2018532797A5 (enExample)
CA3163375A1 (en) Treatment of primary biliary cholangitis with elafibranor
CA2334990A1 (fr) Nouvelle utilisation de composes inhibiteurs de la protease du vih
JPH05194209A (ja) 血管内皮細胞機能改善剤
US8366935B2 (en) Phyllanthus extract
CN100430089C (zh) 美拉加群在制造治疗i型糖尿病的药物中的用途
JP2007277223A (ja) Ｈｔｌｖ−ｉ関連脊髄症の予防・治療剤およびアポトーシス促進剤
Nakamura et al. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
RU2316341C2 (ru) Применение атазанавира в терапии вич-инфекции
US20090221538A1 (en) Methods of treating multiple sclerosis by administering pulse dose calcitriol
WO2016181214A1 (en) Compositions and methods for the treatment of ebola virus disease
Passeron et al. Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin
JP2004533443A (ja) 治療的方法
Yew et al. Ciprofloxacin-induced renal dysfunction in patients with mycobacterial lung infections
RU2817933C1 (ru) Способ лечения атеросклеротических изменений сердечно-сосудистой системы с целью замедления ее старения
US10438128B2 (en) Treatment of autoimmune and inflammatory diseases with the arsenic compounds AS2O3 and/or AS2O5 administered locally
US20240173276A1 (en) Methods and compositions for inhibiting formation of the hiv latent reservoir
US8178497B2 (en) Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA
AU2003234637B2 (en) Methods and compositions for inhibiting HIV replication
Sniecinski Photochemotherapy for GvHD
Li et al. Pharmacodynamics, Pharmacokinetics And Safety Of Alirocumab In Healthy Chinese Subjects

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100310

A621 Written request for application examination

Effective date: 20100310

Free format text: JAPANESE INTERMEDIATE CODE: A621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120904

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130115